The Delhi High Court has upheld a previous order restraining Rajasthan Aushdhalaya from selling medicines under the name Liv-333 or similar names, due to trademark infringement of Himalaya's Liv.52. The court found Rajasthan Aushdhalaya's adoption of 'Liv-333' as intentionally similar to capitalize on Himalaya's established reputation.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Bo5pOHQ
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Delhi HC upholds order to restrain Rajasthan Aushdhalaya from making and selling medicines under Liv-333 name
0 comments:
Post a Comment